[Not Available].
作者信息
Grabbe Stephan, Beissert Stefan, Enk Alexander
机构信息
Hautklinik der Universitätsmedizin, Johannes Gutenberg-Universität, Mainz.
Klinik und Poliklinik für Dermatologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden.
出版信息
J Dtsch Dermatol Ges. 2020 Aug;18(8):810-814. doi: 10.1111/ddg.14194_g.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
J Dtsch Dermatol Ges. 2020 Aug;18(8):810-814. doi: 10.1111/ddg.14194_g.
引用本文的文献
1
Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation.使用新型静脉注射免疫球蛋白制剂成功治疗重度寻常型天疱疮且副作用减少
Dermatol Ther (Heidelb). 2024 Jul;14(7):1969-1974. doi: 10.1007/s13555-024-01191-3. Epub 2024 Jun 12.
2
[Not Available].[不可用]。
J Dtsch Dermatol Ges. 2020 Aug;18(8):787-788. doi: 10.1111/ddg.14186_g.
本文引用的文献
1
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study.在一项初步研究中，使用白细胞介素 6（IL-6）联合评分预测中重度 COVID-19 患者的早期临床恶化：有用性。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2575-2581.e2. doi: 10.1016/j.jaip.2020.06.013. Epub 2020 Jun 19.
2
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.银屑病患者接受全身治疗或生物治疗不会增加患重症 COVID-19 的风险。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
3
All those D-dimers in COVID-19.新冠病毒感染病例中的所有这些D-二聚体。
J Thromb Haemost. 2020 Aug;18(8):2075-2076. doi: 10.1111/jth.14939. Epub 2020 Jun 25.
4
C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation.C反应蛋白水平可能预测新冠病毒疾病加重风险。
Open Forum Infect Dis. 2020 Apr 29;7(5):ofaa153. doi: 10.1093/ofid/ofaa153. eCollection 2020 May.
5
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.新型冠状病毒肺炎患者疾病严重程度的特点和预后因素：北京经验。
J Autoimmun. 2020 Aug;112:102473. doi: 10.1016/j.jaut.2020.102473. Epub 2020 Apr 24.
6
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
7
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.羟氯喹治疗主要为轻症和中症的 2019 冠状病毒病患者：开放标签、随机对照试验。
BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.
8
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.COVID-19 患者心脏移植受者的特征和结局。
JAMA Cardiol. 2020 Oct 1;5(10):1165-1169. doi: 10.1001/jamacardio.2020.2159.
9
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.通过远程医疗评估的意大利北部系统性红斑狼疮队列中的COVID-19感染情况。
Ann Rheum Dis. 2020 Oct;79(10):1382-1383. doi: 10.1136/annrheumdis-2020-217717. Epub 2020 May 12.
10
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.目前可用的静脉用免疫球蛋白含有针对严重急性呼吸综合征冠状病毒 2 抗原的抗体。
Immunotherapy. 2020 Jun;12(8):571-576. doi: 10.2217/imt-2020-0095. Epub 2020 May 12.
Zotero 插件